Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by adding sterile injectable manufacturing capabilities. …
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing Read More